Sonoma Pharmaceuticals Reports FY And Q4 2024 Financial Results
17 Jun 2024 //
ACCESSWIRE
Sonoma Highlights Safety Advantages of its Microcyn Products
27 Mar 2024 //
ACCESSWIRE
Sonoma Launches Two New Products Expanding Its Line of Office Dispense Products
04 Jan 2023 //
ACCESSWIRE
Sonoma Pharma Expands its Partner Network for Oral and Dental Products
20 Jan 2022 //
BUSINESSWIRE
TGA Approves Sonoma, MicroSafe`s Nanocyn Disinfectant & Sanitizer
15 Oct 2021 //
BUSINESSWIRE
Sonoma Pharmaceuticals Launches Its OTC Products in U.S. and Europe
28 Sep 2021 //
BUSINESSWIRE
NovaBay Pharma Expands Avenova® Consumer Marketing through Engagement Program
24 Sep 2020 //
BUSINESSWIRE
Sonoma Pharma Licensing of Antimicrobial HCL2 Acid Solution to Brill Pharma
26 Sep 2018 //
GLOBENEWSWIRE
Realm scraps eye drug after midphase flop, sinking stock
12 Mar 2018 //
FIERCE BIOTECH
Sonoma Pharma receives UAE regulatory approvals for Pediacyn for dermatitis
12 Apr 2017 //
PHARMABIZ